ALMR · Alamar Biosciences Inc. Common Stock
View on chartInsiders & Stakes
| Qiming Corporate GP VI, Ltd. | ▼ Sell | Other | 1,922,329 Shares held | 4/20/2026 | View profile |
| Yuling Luo Chief Executive Officer | ▼ Sell | Other | 1,224,152 Shares held | 4/20/2026 | View profile |
| Shiping Chen Chief Operating Officer | ▲ Buy | Grant | 760,105 Shares held | 4/20/2026 | View profile |
| Illumina Innovation Fund II GP, L.L.C. | ▲ Buy | Open Market | 507,076 Shares held | 4/20/2026 | View profile |
| Timothy Ogden White President | ▲ Buy | Grant | 491,803 Shares held | 4/20/2026 | View profile |
| Justin J. McAnear Chief Financial Officer | ▲ Buy | Grant | 37,220 Shares held | 4/20/2026 | View profile |
| John L. Brottem General Counsel | ▲ Buy | Grant | 29,000 Shares held | 9/14/2026 | View profile |
| Nicholas Naclerio | ▲ Buy | Grant | 5,686 Shares held | 4/20/2026 | View profile |
| Robert P. Ragusa Chief Executive Officer | ▲ Buy | Grant | 5,686 Shares held | 9/1/2026 | View profile |
Transaction History
| John L. Brottem | ▲ Buy | Grant | 29,000 | $0 | 9/14/2026 |
| Robert P. Ragusa | ▲ Buy | Grant | 5,686 | $0 | 9/1/2026 |
| Qiming Corporate GP VI, Ltd. | ▼ Sell | Other | 1,605,645 | — | 4/20/2026 |
| Qiming Corporate GP VI, Ltd. | ▼ Sell | Other | 1,922,329 | — | 4/20/2026 |
| Qiming Corporate GP VI, Ltd. | ▼ Sell | Other | 185,163 | — | 4/20/2026 |
| Shiping Chen | ▼ Sell | Other | 722,885 | — | 4/20/2026 |
| Qiming Corporate GP VI, Ltd. | ▼ Sell | Other | 185,163 | — | 4/20/2026 |
| Qiming Corporate GP VI, Ltd. | ▼ Sell | Other | 6,881,410 | — | 4/20/2026 |
| Qiming Corporate GP VI, Ltd. | ▼ Sell | Other | 1,605,645 | — | 4/20/2026 |
| Qiming Corporate GP VI, Ltd. | ▼ Sell | Other | 1,922,329 | — | 4/20/2026 |
| Qiming Corporate GP VI, Ltd. | ▼ Sell | Other | 185,163 | — | 4/20/2026 |
| Qiming Corporate GP VI, Ltd. | ▼ Sell | Other | 6,881,410 | — | 4/20/2026 |
| Qiming Corporate GP VI, Ltd. | ▼ Sell | Other | 6,881,410 | — | 4/20/2026 |
| Qiming Corporate GP VI, Ltd. | ▼ Sell | Other | 1,605,645 | — | 4/20/2026 |
| Qiming Corporate GP VI, Ltd. | ▼ Sell | Other | 1,922,329 | — | 4/20/2026 |
| Illumina Innovation Fund II GP, L.L.C. | ▼ Sell | Other | 4,588,364 | — | 4/20/2026 |
| Illumina Innovation Fund II GP, L.L.C. | ▼ Sell | Other | 5,510,516 | — | 4/20/2026 |
| Illumina Innovation Fund II GP, L.L.C. | ▼ Sell | Other | 5,510,516 | — | 4/20/2026 |
| Illumina Innovation Fund II GP, L.L.C. | ▼ Sell | Other | 346,020 | — | 4/20/2026 |
| Illumina Innovation Fund II GP, L.L.C. | ▼ Sell | Other | 271,782 | — | 4/20/2026 |
| Illumina Innovation Fund II GP, L.L.C. | ▲ Buy | Open Market | 235,294 | $4.0M | 4/20/2026 |
| Timothy Ogden White | ▼ Sell | Other | 454,583 | — | 4/20/2026 |
| Timothy Ogden White | ▼ Sell | Other | 454,583 | — | 4/20/2026 |
| Timothy Ogden White | ▲ Buy | Grant | 37,220 | $0 | 4/20/2026 |
| Shiping Chen | ▼ Sell | Other | 320,511 | — | 4/20/2026 |
| Shiping Chen | ▼ Sell | Other | 72,853 | — | 4/20/2026 |
| Shiping Chen | ▼ Sell | Other | 722,885 | $0 | 4/20/2026 |
| Shiping Chen | ▲ Buy | Grant | 37,220 | $0 | 4/20/2026 |
| Yuling Luo | ▼ Sell | Other | 1,386,746 | — | 4/20/2026 |
| Yuling Luo | ▼ Sell | Other | 364,268 | — | 4/20/2026 |
| Yuling Luo | ▼ Sell | Other | 1,864,065 | — | 4/20/2026 |
| Yuling Luo | ▼ Sell | Other | 1,864,065 | — | 4/20/2026 |
| Yuling Luo | ▲ Buy | Grant | 76,509 | $0 | 4/20/2026 |
| Yuling Luo | ▼ Sell | Other | 1,224,152 | — | 4/20/2026 |
| Yuling Luo | ▼ Sell | Other | 1,224,152 | — | 4/20/2026 |
| Yuling Luo | ▼ Sell | Other | 1,224,152 | — | 4/20/2026 |
| Justin J. McAnear | ▲ Buy | Grant | 37,220 | $0 | 4/20/2026 |
| Nicholas Naclerio | ▼ Sell | Other | 922,152 | — | 4/20/2026 |
| Nicholas Naclerio | ▼ Sell | Other | 5,510,516 | — | 4/20/2026 |
| Nicholas Naclerio | ▲ Buy | Open Market | 235,294 | $4.0M | 4/20/2026 |
| Nicholas Naclerio | ▲ Buy | Grant | 5,686 | $0 | 4/20/2026 |
| Illumina Innovation Fund II GP, L.L.C. | ▼ Sell | Other | 922,152 | — | 4/20/2026 |
| Nicholas Naclerio | ▼ Sell | Other | 5,510,516 | — | 4/20/2026 |
| Nicholas Naclerio | ▼ Sell | Other | 346,020 | — | 4/20/2026 |
| Nicholas Naclerio | ▼ Sell | Other | 271,782 | — | 4/20/2026 |
| Nicholas Naclerio | ▼ Sell | Other | 4,588,364 | — | 4/20/2026 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Alamar Biosciences Sets Q3 2026 Earnings Release Date
Alamar Biosciences will report its third‑quarter 2026 financial results on November 3, 2026. The company’s latest article highlights a growing focus on its consumables business, suggesting a potential shift in revenue streams. Investors may watch the earnings release for updates on this strategy.
Alamar Biosciences Sets Q3 2026 Earnings Release Date. Alamar Biosciences will report its third‑quarter 2026 financial results on November 3, 2026. The company’s latest article highlights a growing focus on its consumables business, suggesting a potential shift in revenue streams. Investors may watch the earnings release for updates on this strategy.